People In Brief
This article was originally published in The Gray Sheet
Inamed rearranges execs: Firm appoints CFO Robert Vaters to new position of Exec VP-strategy and corporate development. Vaters duties will include developing corporate strategy, pursuing business growth opportunities and generating new sources of revenue, Inamed states in a Nov. 8 release. Senior VP and Corporate Controller Declan Daly replaces Vaters as CFO. Both men will report directly to President & CEO Nicholas Teti. One potential growth area for the company centers around its BioEnterics Lap-Band laparoscopic adjustable gastric band device. CMS' Medicare Coverage Advisory Committee recently found the Lap-Band procedure to produce a clinically important net health benefit for morbidly obese patients with co-morbidities (1"The Gray Sheet" Nov. 8, 2004, p. 10). The decision could lead to expanded coverage of the device. U.S. Lap-Band revenue helped boost Inamed's Obesity Intervention segment sales 37% to $22.2 mil. in Q3...
You may also be interested in...
Laparoscopic adjustable gastric banding produces a clinically important net health benefit for morbidly obese patients with co-morbidities, CMS' Medicare Coverage Advisory Committee agreed Nov. 4 in Baltimore, Md
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.